Overview
Laboratoria Natury provides contract manufacturing of dietary supplements in liquid forms such as syrups, drops and vitamin tonics. It also makes pectin gummies and Bites supplements in chocolate form for adults and children. The company supports customers from recipe development and registration through production trials to the finished product.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-01-01. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 31, 2025 | Regional investment aid | $171,859 | Dolina Łąk sp. z o.o. | |
| Apr 2, 2024 | Regional investment aid | $92,269 | Dolina Łąk sp. z o.o. | |
| Jun 30, 2023 | Regional investment aid | $28,436 | Dolina Łąk sp. z o.o. |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
A) In the case of a one-person management board, the sole member of the management board independently; B) in the case of a multi-member management board, the President of the Management Board independently, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Farmaceutici Procesma S.p.a Societa Benefit | 8,401 | $1,134,656.94 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Wojciech Andrzej Furtak (46)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Global Pharma CmS.A. | $24,132,016.98 | globalpharma.pl | |
| Master PharmS.A. | $23,116,954.19 | masterpharm.pl | |
| Dary Naturysp. z o.o. | $16,325,774.75 | darynatury.pl | |
| ALG Pharmasp. z o.o. | $16,237,368.88 | algpharma.pl | |
| CelikoS.A. | $13,080,041.65 | celiko.com.pl | |
| Premium Rosasp. z o.o. | $10,653,161.35 | premiumrosa.eu | |
| Norsa Pharmasp. z o.o. | $9,111,390.60 | norsapharma.eu | |
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | |
| Chias Brothers Europesp. z o.o. | $4,935,357.96 | chias.eu | |
| Noble Healthsp. z o.o. | $4,558,481.50 | noblehealth.com |
Change history
| Date | Event |
|---|---|
| 2019-12-05 | Address change (Zawieprzycka 8d, 20-228, Lublin → Ul. Józefa Franczaka "lalka" 18, 20-325, Lublin) |
| 2017-12-08 | Share capital change (4,200,000.00 PLN → 4,200,500.00 PLN) |
| 2014-04-16 | Share capital change (4,100,000.00 PLN → 4,200,000.00 PLN) |
| 2012-03-07 | Address change (Rapackiego 19, 20-150, Lublin → Zawieprzycka 8d, 20-228, Lublin) |
| 2012-02-28 | Share capital change (4,000,000.00 PLN → 4,100,000.00 PLN) |
FAQ
Last updated: 2026-07-20